Vascular Closure Device is a Critical Medical Device for Treatment of Punctured Arteries and Prevents Accumulation of Plaque
Vascular Closure Device (VCD) was introduced to medical practice in 1994. The primary purpose of these therapeutic devices is to reduce complications following percutaneous mini-bullet and femoral artery access and improve patient comfort during surgery. One of the major advantages of a VCD is the prevention of femoral artery recession or femoral artery wall crush. These devices are placed around the femoral artery or the largest artery in the body, the femoral artery originates from the tibia to the knee and provides one of the major blood flow to the leg. This large artery is susceptible to early narrowing by plaque buildup from within, particularly from small platelets, microVascular Closure Device-organisms, and atherosclerotic plaques.
Plaque can easily deposit onto the arterial walls and restrict blood flow, leading to the decreased blood supply to the leg and painful symptoms such as leg pain, tingling, numbness, and impaired walking. A VCD prevents or greatly reduces the risk of the femoral artery wall crushing or the accumulation of plaque within the walls of the artery. Plaque buildup requires significant time for formation. Vascular Closure Device i ntroductions immediately stop the process of arterial plaque buildup by reducing the concentration and size of the platelets within the narrowed artery. Platelets normally play a major role in the regulation and growth of new blood vessels, especially in the heart. They adhere to the arterial walls and actively participate in blood clotting activities.
A vascular closure device is used in conjunction with surgical scissors to close off a damaged area. This prevents blood from flowing beyond the damaged site, which in turn prevents the spread of infection to other areas of the body. A continuous research in Germany, Mexico, and Japan is leading to the introduction of novel vascular closure devices. Recently, a New York-based company with a subsidiary in Germany launched a universal large bore vascular closure system designed for arteries and veins.
Comments
Post a Comment